Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype

Nature Genetics

Volumn 21, Issue 1, 1999, Pages 111-1114

  Jiang, Xu Rong ^a   Jimenez, Gretchen ^b   Chang, Edwin ^a   Frolkis, Maria ^a   Kusler, Brenda ^a   Sage, Marijke ^c   Beeche, Michelle ^b   Bodnar, Andrea G ^a   Wahl, Geoffrey M ^b   Tlsty, Thea D ^c   Chiu, Choy Pik ^a  

^a GERON CORPORATION   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; CELL CYCLE; CELL DENSITY; CELL TRANSFORMATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; PHENOTYPE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN FIBROBLAST;

NON-PROGRAMMATIC;

ASPARTIC ACID; CELL LINE; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA-BINDING PROTEINS; ENZYME INHIBITORS; HUMANS; HYDROXYUREA; NUCLEIC ACID SYNTHESIS INHIBITORS; PHENOTYPE; PHOSPHONOACETIC ACID; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTEINS; RETINOBLASTOMA PROTEIN; RNA; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 0032923742     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/5056     Document Type: Article

References (23)

1. Bodnar, A.G. et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352 (1998).
2. Weinrich, S.L. et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nature Genet. 17, 498-502 (1997).
3. McKay, B.S. & Burke, J.M. Separation of phenotypically distinct subpopulations of cultured human retinal pigment epithelial cells. Exp. Cell Res. 213, 85-92 (1994).
4. Weinberg, R.A. The retinoblastoma protein and cell cycle control. Cell 81, 323-330 (1995).
5. Alcorta, D.A. et al. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl Acad. Sci. USA 93, 13742-13747 (1996).
6. Linke, S.P., Clarkin, K.C., Di Leonardo, A., Tsou, A. & Wahl, G.M. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage Genes Dev. 10, 934-947 (1996).
7. Pedrali-Noy, G. et al. Synchronization of HeLa cell cultures by inhibition of DNA polymerase α with aphidicolin. Nucleic Acids Res. 8, 377-387 (1980).
8. White, A.E., Livanos, E.M. & Tlsty, T.D. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev. 8, 666-677 (1994).
9. Yin, Y., Tainsky, M.A., Bischoff, F.Z., Strong, L.C. & Wahl, G.M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70, 937-948 (1992).
10. Livingstone, L.R. et al. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70, 923-935 (1992).
11. Schwartz, D., Almog, N., Peled, A., Goldfinger, N. & Rotter, V. Role of wild type p53 in the G2 phase: regulation of the γ-irradiation-induced delay and DNA repair. Oncogene 15, 2597-2607 (1997).
12. Khan, S.H. & Wahl, G.M. p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest. Cancer Res. 58, 396-401 (1998).
13. Gualberto, A., Aldape, K., Kozakiewicz, K. & Tlsty, T.D. An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control. Proc. Natl Acad. Sci. USA 95, 5166-5171 (1998).
14. Freedman, V.H. & Shin, S.I. Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3, 355-359 (1974).
15. Shin, S., Freedman, V.H., Risser, R. & Pollack, R. Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc. Natl Acad. Sci. USA 72, 4435-4439 (1975).
16. Saksela, E. & Moorhead, P.S. Aneuploidy in the degenerative phase of serial cultivation of human cell strains. Genetics 50, 390-395 (1963).
17. Benn, PA. Specific chromosome aberrations in senescent fibroblast cell lines derived from human embryos. Am. J. Hum. Genet. 28, 465-473 (1976).
18. Johnson, T.E. et al. Karyotypic and phenotypic changes during in vitro aging of human endothelial cells. J. Cell Physiol. 150, 17-27 (1992).
19. Lee, H.W. et al. Essential role of mouse telomerase in highly proliferative organs. Nature 92, 569-574 (1998).
20. Wright, W.E., Piatyszek, M.A., Rainey, W.E., Byrd, W. & Shay, J.W. Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet 18, 173-179 (1996).
21. Chiu, C.P. et al. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 14, 239-248 (1996).
22. Mullen, P., Ritchie, A., Langdon, S.P. & Miller, W.R. Effect of matrigel on the tumorigenicity of human breast and ovarian carcinoma cell lines. Int. J. Cancer 67, 816-820 (1996).
23. Noel, A. et al. Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts. Br. J. Cancer 68, 909-915 (1993).